Última Hora: "Novo Banco coloca PME como prioridade - Dinheiro Vivo" Thu, 19 Oct 2017 16:22:52 GMT    ""O Estado não se mete na gestão da TAP" - TSF Online" Sat, 21 Oct 2017 00:06:25 GMT    "Governo de Passos suspeito de corrupção na Operação Marquês - Público.pt" Wed, 18 Oct 2017 05:38:08 GMT    "Cerca de 3,6 milhões de pensões aumentadas em janeiro - Observador" Fri, 20 Oct 2017 16:56:00 GMT    "Comércio entre Macau e países lusófonos com "dimensão frustrante" -- economista - Diário de Notícias - Lisboa" Sat, 21 Oct 2017 08:05:00 GMT   "Altice acusa NOS de não aceitar a livre concorrência como regra do jogo - Expresso" Fri, 20 Oct 2017 18:06:00 GMT    "Governo quer limites de captura de sardinha para Portugal e Espanha entre 13,5 e 14 mil toneladas - Observador" Fri, 20 Oct 2017 16:26:42 GMT    "Infante. Vem aí o primeiro satélite criado em Portugal - Diário de Notícias - Lisboa" Wed, 18 Oct 2017 21:54:00 GMT    "Mota-Engil informa que a Lineas vendeu participações na SCUTVIAS e PORTVIAS - RTP" Fri, 20 Oct 2017 16:27:00 GMT    "TAP vai contratar 400 para abrir novas rotas. E não só no Porto - Dinheiro Vivo" Fri, 20 Oct 2017 07:29:23 GMT      Para mais notícias, clique aqui.

Área de Acesso
       
       
Lembrar Sempre 
(Login BolsaPT & Canal Forex)

Mostrar Notícias:
 Ver notícias de outros activos

Pesquisa de notícias relativas à acção Sepracor Inc. (ordenadas pela data):


Asthma Medication Market ? Global Industry Size, Growth Analysis, Trends, Demand and Segment Forecast To 2022
Medgadget (blog)
Inc, AstraZeneca plc, Roche Holdings Ltd, Genentech Inc, Sepracor, Inc, Schering-Plough Corp, Sanofi-Aventis, Theravance Inc. Competitive Assessment: In-depth assessment of market shares, growth strategies, products, distribution networks ...

e mais »

ContraFect (CFRX) Names Lisa Ricciardi as COO
StreetInsider.com
... firms and biotechnology companies. Ms. Ricciardi currently serves on the board United Drug Healthcare Group, PLC, and was a prior board member Chimerix Inc. as well as Sepracor Inc., which was sold to Dainippon Sumitomo for $2.6 billion.

e mais »

Kala Pharmaceuticals Appoints Andrew I. Koven to Board of Directors
Business Wire (press release)
From 2007-2010, Mr. Koven served as Executive Vice President, General Counsel and Corporate Secretary at Sepracor Inc., where he was responsible for the company's legal and government affairs departments and Corporate Secretarial function until its ...

e mais »

Form 8-K Kala Pharmaceuticals, For: Sep 28
StreetInsider.com
On September 28, 2017, the Board of Directors (the ?Board?) of Kala Pharmaceuticals, Inc. (the ?Company?) increased the size of the Board from eight to nine directors and, following the recommendation of the Nominating and Corporate Governance ...


Belgium's Ablynx enters the US market
PMLiVE
Ablynx Belgium biopharmaceutical company Ablynx has established a beachhead in the US, setting up a new subsidiary for that market. Ablynx, Inc will be led by newly-appointed general manager Daniel Schneider, who will be based on the east coast.


Pediatric Internalizing Disorders: October 2017
Healio
Andrew A. Nierenberg, MD, has disclosed the following relevant financial relationships: Appliance Computing Inc. (Mindsite); Astra Zeneca; Brain Cells, Inc.; Brandeis University; Bristol Myers Squibb; Clintara, Dianippon Sumitomo/Sepracor; Eli Lilly ...


Asthma Medication Market Benefit and Volume 2017 with Status and Prospect to 2022
TS Global Market Updates (press release)
Inc, Merck & Co. Inc, AstraZeneca plc, Roche Holdings Ltd, Genentech Inc, Sepracor, Inc, Schering-Plough Corp, Sanofi-Aventis, Theravance Inc. The new vendor entrants in the market are finding it hard to compete with the international vendors based on ...


Global Asthma Medication Market Outlook by Product Overview, Application and Regions 2022
satPRnews (press release)
This Report Provides in depth survey of Asthma Medication Market using various Market Research Analysis.It also provides the details about the major Key Players in the market based on the quality of the products,profiling and financial report of industry.

e mais »

Acer Therapeutics Appoints Dr. William T. Andrews as Chief Medical Officer
GlobeNewswire (press release)
CAMBRIDGE, Mass., Oct. 05, 2017 (GLOBE NEWSWIRE) -- Acer Therapeutics Inc., (Nasdaq:ACER), a pharmaceutical company focused on the acquisition, development and commercialization of therapies for serious rare and ultra-rare diseases with critical unmet ...

e mais »

Desloratadine Market Demand Analysis by Experts 2017 To 2022
Otaku Reports
Companies Profiled in this report includes: Pfizer, Teva, Wante Pharmaceutical, Novartis India Limited, Mylan, Sepracor, Sandoz, Apollo Pharmaceuticals, GSK, Mayne Pharma Inc, Abhilasha Pharma Pvt, Abbott, Takeda, Schering-Plough, Nanjing Hicin ...

e mais »

ZIOPHARM Appoints Amy Trevvett Vice President of Investor Relations and Corporate Communications
GlobeNewswire (press release)
Prior to HeartWare, Ms. Trevvett served in communications and investor relations roles at both Alkermes, Inc., a global biopharmaceutical company developing innovative medicines for the treatment of central nervous system (CNS) diseases, and Sepracor, ...

e mais »

Frequency Therapeutics Announces its Board of Directors and the Appointment of Marc A. Cohen as Chairman
Yahoo Finance
The Board Members include Tim Barberich, founder and former CEO and Chairman of Sepracor, Inc. (now known as Sunovion), Marc Kozin, Senior Advisor and former President of L.E.K. Consulting, Robert S. Langer, Sc.D., Frequency Co-founder and the ...

e mais »

Flex Pharma Names William K. McVicar, Ph.D. as President, Research & Development
Business Wire (press release)
Flex Pharma, Inc. (NASDAQ: FLKS), focused on developing treatments for cramps and spasms associated with severe neurological diseases, today announced the appointment of William K. McVicar, Ph.D., as President of Research and Development. ... ?With ...

e mais »

Rewire

Religious Imposition Proponents Find an Ally in the White House
Rewire
Stirrup worked as a senior legislative adviser at Venable LLP from 2003 to 2008. The firm's clients between those years included AstraZeneca Pharmaceuticals, Sepracor Inc, and the National Association of Spine Specialists. Another hire, Anna Pilato, is ...


Reuters

Dainippon to buy US drug firm Sepracor for $2.6 billion
Reuters
It will also gain Sepracor's insomnia drug Lunesta, asthma drug Xopenex and an experimental epilepsy drug. ?We anticipate our business will shrink if we focus only on Japan, where medical prices are under pressure,? Dainippon Sumitomo President Masayo ...
Drugmaker Sepracor Accepts $2.6B Buyout Offer from Japan's DainipponXconomy

todos os 485 artigos de notícias »

Sunovion Pharmaceuticals Inc. Announces Company Name Change
Business Wire (press release)
BUSINESS WIRE)--Sunovion Pharmaceuticals Inc. (Sunovion), formerly Sepracor Inc. (Sepracor), announced today that it has formally changed its name. The change occurs on approximately the one year anniversary of the acquisition of Sepracor by ...

e mais »

PR Newswire (press release)

Genzyme Corporation Pays $5.885 Million To Resolve False Claims Act Allegations; Judgment Involving Cases ...
PR Newswire (press release)
Those defendants include Allergan, Inc., Amgen, Inc., Bradley Pharmaceuticals, Inc., Eisai, Inc., Mallincrodt, Inc., Novo Nordisk, Inc., Reliant Pharmaceuticals, Inc., Sepracor, Inc., and Upsher-Smith Laboratories, Inc. The settlement with Genzyme ...

e mais »

TheChronicleHerald.ca

PEI's BioVectra buys former Sepracor plant in Windsor
TheChronicleHerald.ca
A Charlottetown drug manufacturer has acquired a mothballed Windsor pharmaceutical plant and plans to reopen the facility in early 2016. BioVectra Inc. purchased the former Sepracor Canada (Nova Scotia) Ltd. facility in May. The Sepracor operation ...
Charlottetown's BioVectra expanding, setting up in WindsorHants Journal

todos os 5 artigos de notícias »

Boston Globe

FDA approves Marlborough company's epilepsy drug
Boston Globe
An epilepsy tablet made by Marlborough-based Sunovion Pharmaceuticals Inc. won US approval Friday to be sold as a primary therapy for hundreds of thousands of Americans suffering from partial-onset seizures. The drug, called Aptiom, has been on the ...

e mais »

Sunovion Celebrates Five-Year Anniversary Milestone
Business Wire (press release)
MARLBOROUGH, Mass.--(BUSINESS WIRE)--Sunovion Pharmaceuticals Inc. (Sunovion) announced today that it is celebrating its five-year anniversary. Sunovion was established in October 2010 following the integration of Sepracor Inc. and Dainippon ...

e mais »

Sunovion Pharmaceuticals to Acquire Cynapsus Therapeutics
Business Wire (press release)
MARLBOROUGH, Mass. & TORONTO--(BUSINESS WIRE)--Sunovion Pharmaceuticals Inc. (Sunovion) and Cynapsus Therapeutics Inc. (Cynapsus) (NASDAQ: CYNA) (TSX: CTH) today announced that the companies have signed a definitive agreement ...

e mais »

CoLucid Pharmaceuticals Announces Election of Mark Corrigan, MD, to Board of Directors
GlobeNewswire (press release)
Dr. Corrigan was Executive Vice President, Research & Development of Sunovion Pharmaceuticals Inc. (formerly Sepracor Inc.) from April 2003 until December 2009. Prior to joining Sunovion Pharmaceuticals, he spent 10 years with Pharmacia & Upjohn, Inc.

e mais »

PMLiVE

Astellas appoints ethics and compliance and US legal leaders
PMLiVE
Wanda brings over 20 years of experience in the pharmaceutical industry, having held senior leadership positions at Schering-Plough and Sepracor Inc, a US-based biopharmaceutical company. Prior to joining Astellas as deputy general counsel and head of ...


RXi Pharmaceuticals Announces Closing of $11.5 Million Underwritten Public Offering and Full Exercise of Over ...
PR Newswire (press release)
Sc. and Chief Development Officer, Pamela Pavco, Ph.D. Other participants included OPKO Health, Inc. (NASDAQ: OPK), an existing investor of RXi, and Timothy Barberich, co-founder of MirImmune, Inc. and former CEO and Chairman of Sepracor, Inc.

e mais »

Flex Pharma Names William McVicar President and Chief Executive Officer
Business Wire (press release)
Prior to Inotek, he served as Vice President of Development Operations at Sepracor, where he oversaw the development, FDA review, and approval of multiple NDAs and SNDAs, including BROVANA®, XOPENEX MDI®, and XOPENEX's pediatric approval, which were ...

e mais »

Envisia Therapeutics Appoints William Yelle Executive Chairman
PR Newswire (press release)
Prior to Aldea, Yelle was Senior Vice President of Corporate Development for Sunovion Pharmaceuticals Inc. (formerly Sepracor Inc.). While at Sepracor, he was instrumental in the company's transition from an early stage clinical organization into a ...

e mais »

Boston Globe (registration)

Sepracor joins ranks of growing Mass. firms
Boston Globe (registration)
Sepracor Inc., the Marlborough drug maker behind the Lunesta sleep aid, plans to nearly double the size of its headquarters, the latest in a wave of expansion by Massachusetts life sciences companies. Sepracor executives said the company will build a ...


Crain's Detroit Business

Detroit-based Trimaran Pharma attracts experienced executives
Crain's Detroit Business
based Sepracor Inc. when it launched Lunesta, an insomnia drug that was later named by Forbes Magazine as the fifth most successful launch in pharma history, eventually surpassing $1 billion in annual sales. Piskorski also has startup experience.


Sunovion Pharmaceuticals Canada Inc. Announces Company Name Change
Canada NewsWire (press release)
Sepracor Pharmaceuticals, Inc. changes name, maintains commitment to developing scientifically-advanced central nervous system, cardiovascular disease and infectious disease therapies that improve patients' lives. MISSISSAUGA, ON, Aug. 17, 2011 ...

e mais »

Hants Journal

Windsor pharmaceutical company closing mid-2013
Hants Journal
A pharmaceuticals plant in Windsor is slated for closure in mid-2013. Sunovion Pharmaceuticals Inc., the Massachusetts-based parent company of Sepracor Canada Ltd., released a prepared statement to the media Dec. 5 to inform the public of the closure, ...
Shutdown at Windsor drug plant will cost 32 jobsTheChronicleHerald.ca

todos os 8 artigos de notícias »

Largura do Site:

 Imagem de Fundo:

Copyright@1998-2017 - BolsaPT.com, todos os direitos reservados.
Fórum de Bolsa Cotações de Bolsa Notícias de Bolsa Chat de Bolsa Disclaimer Recursos para Webmasters